Moderna Inc. buy UBS Group AG
Start price
08.01.25
/
50%
€43.07
Target price
08.01.26
€93.16
Performance (%)
-36.41%
Price
23.12.25
€27.39
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Moderna Inc. is performing very badly with a performance of -36.41%. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -5.044% | -5.044% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $108.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat